Tarsus Pharmaceuticals, Inc. (TARS)
81.32
+1.77
(+2.22%)
USD |
NASDAQ |
Dec 10, 16:00
81.25
-0.07
(-0.09%)
After-Hours: 20:00
Tarsus Pharmaceuticals Shareholders Equity (Quarterly): 335.08M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Codexis, Inc. | 38.54M |
| Precigen, Inc. | 41.87M |
| Celcuity, Inc. | 116.96M |
| Liquidia Corp. | 22.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 534.56M |
| Total Liabilities (Quarterly) | 199.48M |
| Debt to Equity Ratio | 0.2462 |
| Current Ratio | 4.286 |
| Net Debt Paydown Yield | -0.08% |